Brenda M. Sandmaier - Concepedia

Author

Brenda M. Sandmaier

Also Known As

Alexander Fefer, B M Sandmaier, B Sandmaier, B. M. Sandmaier, B. Sandmaier, B.M Sandmaier, B.M. Sandmaier, BRENDA M. SANDMAIER, BRENDA SANDMAIER, Barry Storer

669

Publications

36.1K

Citations

H-Index

133

Concepts

All Affiliations

Fred Hutch Cancer Center University of Washington University of Washington Medical Center Medical College of Wisconsin Stanford University

About

Brenda M. Sandmaier is an author at Fred Hutch Cancer Center specializing in medicine, cell transplantation, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	79	5.9K
2	Health Sciences	17	23	2.1K
3	Public Health	3	3	482
4	Engineering	2	2	179
5	Natural Sciences	1	1	68

Brenda M. Sandmaier

276

Publications

33.5K

Citations

H-Index

Page 1

	Year	Citations
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT Mohamed L. Sorror, Michael B. Maris, Rainer Storb, Blood	2005	2.9K
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide Leo Luznik, Paul V. O’Donnell, Heather J. Symons, Biology of Blood and Marrow Transplantation	2008	1.9K
Defining the Intensity of Conditioning Regimens: Working Definitions Andrea Bacigalupo, Karen K. Ballen, Doug Rizzo, Biology of Blood and Marrow Transplantation	2009	1.7K
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation Ted Gooley, Jason W. Chien, Steven A. Pergam, New England Journal of Medicine	2010	1.5K
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects Peter A. McSweeney, Dietger Niederwieser, Judith A. Shizuru, Blood	2001	1.4K
Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research Sergio Giralt, Karen K. Ballen, Douglas Rizzo, Biology of Blood and Marrow Transplantation Transplantation MedicineBmt Tandem MeetingsHematologyClinical TrialsInternational Blood	2009	868
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation Marco Mielcarek, Paul J. Martin, Wendy M. Leisenring, Blood	2003	555
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning Takahiro Fukuda, Michael Boeckh, Rachel A. Carter, Blood	2003	464
Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases Dietger Niederwieser, Michael B. Maris, Judith A. Shizuru, Blood	2003	455
Cord-Blood Transplantation in Patients with Minimal Residual Disease Filippo Milano, Ted Gooley, Brent L. Wood, New England Journal of Medicine	2016	429

Page 1